The old Medtronic Infuse controversy is being stirred up again.The Milwaukee Journal Sentinel today published a story on Thomas Zdeblick, the chairman of the Department of Orthopedics & Rehabilitation at the University of Wisconsin-Madison, who has received more than $25 million in royalties from Medtronic since 2003.The article calls to question Zdeblick’s position as chairman [...]

Madison-based Echometrix expects to offer EchoSoft, software to improve ultrasound diagnosis and management of tendon and ligament injuries, by year’s end, said CEO Sam Adams. Last week, the four-year-old startup filed Securities and Exchange Commission documents seeking to raise $1 million toward that goal.

Tim Mulcahy’s eyes lit up as the thought suddenly seized him.“Here’s what we can propose,” said Mulcahy, vice president of research at the University of Minnesota. “Perhaps the university is too risk averse in our assessment” of potential startups.“We will make any of those technologies and potential companies that we pass on immediately available for [...]

Ever heard of the I-Q Corridor? Unless you’re an economic development geek, probably not.The concept, first penned in a little-noticed Wisconsin Technology Council white paper, envisions an economic superhighway of sorts connecting the Twin Cities, Madison, Wis. and Chicago along interstates 90 and 94. The “I” stands for ideas, innovation, investment, intellectual property while the [...]

Stratatech Corp. has raised $3 million to continue developing a genetically engineered human skin substitute, according to a regulatory filing.The fundraise comes in the form of debt, options, warrants or other securities, the document filed with the Securities and Exchange Commission said. Robert Barnard, a company official, declined comment on the funding.The company’s lead product [...]

Rep. Ann Lenczewski’s opposition to angel credits flies in the face of evidence, experts, and the collective political and business will of Minnesota.

The park should be Minnesota’s answer to Research Triangle Park in North Carolina, a place where academics, scientists, investors and entrepreneurs converge to create breakthrough innovations developed and sold by homegrown companies, said Peter Bianco, director of lifescience business development of Halleland Health Consulting in Minneapolis. Bianco is spearheading the project.

A Harvard Medical School Student caused a stir four years ago that has grown into a movement against drug company involvement with medical faculty. Medical schools at Harvard and the University of Wisconsin-Madison are considering strengthening conflict-of-interest rules that guide doctor relationships with drug and medical device companies.